Physician

General Surgery

Dr. Keith F. Fournier, MD

Doctor Keith F. Fournier, MD is an expert in the field of General Surgery. He attended Geisel School of Medicine at Dartmouth. Geisel School of Medicine at Dartmouth is ranked 37 in research and 29 in primary care medicine Keith Fournier is also published. He has 17 publications published. The lastest publication: "Challenges of efficacy assessments in pseudomyxoma peritonea.' Dr. Keith F. Fournier accepts all Medicare patients.

Publications

Challenges of efficacy assessments in pseudomyxoma peritonea.
A Simplified Preoperative Assessment Predicts Complete Cytoreduction and Outcomes in Patients with Low-Grade Mucinous Adenocarcinoma of the Appendix.
Improved Survival with Anti-VEGF Therapy in the Treatment of Unresectable Appendiceal Epithelial Neoplasms.
Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the deLivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in...
The palliative index: predicting outcomes of emergent surgery in patients with Cancer.
Complete Cytoreduction and HIPEC Improves Survival in Desmoplastic Small Round Cell Tumor.
A focused curriculum in surgical oncology for the third-year medical students.
Improving the AJCC/TNM staging for adenocarcinomas of the appendix: the prognostic impact of histological grade.
High-level Microsatellite Instability in Appendiceal Carcinomas.
Pathologic complete response in poorly differentiated adenocarcinomas of the appendix: A case series.
Varying malignant potential of appendiceal Neuroendocrine tumors: Importance of histologic subtype.
Localized Gastric Cancer Treated with Chemoradation without Surgery: UTMD Anderson Cancer Center Experience.
Is malignant dedifferentiation for mucinous appendiceal neoplasms a valid phenomenon or merely histopathologic ambiguity?
Neuroendocrine and mucinous differentiation in signet ring cell carcinoma of the stomach: evidence for a common cell of origin in composite tumors.
Epithelial to mesenchymal transition contributes to drug resistance in pancreatic Cancer.
DNA damage-induced protein 14-3-3 sigma inhibits protein kinase B/Akt activation and suppresses Akt-activated Cancer.

Schools

Dartmouth College
Eastern Virginia Med Center Norfolk Va

Procedures Preformed

Appendectomy, Open
Colectomy
Cystectomy
Cystotomy
View All

Conditions Treated

Abdominal Pain
Adrenal Gland Cancer
Anorectal Abscess
Appendicitis
View All

Doctors Specialties

General Surgery

Accepted Insurances

Choice Plus POS II
Amerigroup (Wellpoint)
Blue Card PPO
Blue Choice
Cigna HMO
Cigna PPO
Great West Healthcare-Cigna PPO
LocalPlus
Open Access Plus
Commercial Insurance Company
Coventry Health Care
First Health (Coventry Health Care) PPO
GEHA
Choice Care PPO
Medicare MCR
MHealth Insured
MultiPlan PPO
PHCS Network PPO
Choice Plus POS
Navigate HMO
Navigate POS
Options PPO
United Healthcare

Education

Eastern Virginia Medical School
Geisel School of Medicine at Dartmouth

Drug Facts

NPI NUMBER		1649290230
NPPES Provider LastName		FOURNIER
NPPES Provider FirstName		KEITH
NPPES Provider ZIPCode		770304095
NPPES Provider State		TX
Specialty Description		Surgical Oncology
Total Claim Count		75.0
Distinct Opioid Count		1.0
Opioid Claim Count		19.0
Percent Opioid Claims		25.33

Helpful Reviews

Give Anonymous Review

Medicare Facts

National Provider Identifier [NPI]	1649290230
Last Name Of The Provider	FOURNIER
First Name Of The Provider	KEITH
View All

Similar Doctors

	Dr. Jason Au, MD
	Dr. Catherine L. Akay, MD This Doctor is OpenDoctor Recommended.
	Dr. Audencio Alanis, MD This Doctor is OpenDoctor Recommended.
	Dr. Elegy L. Etter II, MD This Doctor is OpenDoctor Recommended.
	Dr. Edward L. Patten, MD This Doctor is OpenDoctor Recommended.
	Dr. Diana M. Hook-Dufresne, MD This Doctor is OpenDoctor Recommended.
	Dr. Ana K. Islam, MD
	Dr. Uma R. Phatak, MD
	Dr. Christian Moya, MD This Doctor is OpenDoctor Recommended.
	Dr. Karoly Varga, MD This Doctor is OpenDoctor Recommended.